Factors determining first influenza vaccination among individuals with type 2 diabetes in the CONSTANCES cohort by age group (younger than 65 years or 65 and older)
Vaccine coverage against influenza is suboptimal among people with diabetes. Our principal objective was to study and compare the factors related to a first influenza vaccination in individuals with type 2 diabetes according to age group (<65 years and ≥ 65 years) and then to compare the older ag...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2437911 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841558750591188992 |
|---|---|
| author | Sylvain Paquet Virginie Ringa Henri Panjo Jeanne Sassenou Marie Zins Laurent Rigal |
| author_facet | Sylvain Paquet Virginie Ringa Henri Panjo Jeanne Sassenou Marie Zins Laurent Rigal |
| author_sort | Sylvain Paquet |
| collection | DOAJ |
| description | Vaccine coverage against influenza is suboptimal among people with diabetes. Our principal objective was to study and compare the factors related to a first influenza vaccination in individuals with type 2 diabetes according to age group (<65 years and ≥ 65 years) and then to compare the older age group with diabetes to the general population of that age. This is a descriptive cross-sectional study within the French Constances cohort. The study populations were composed of people with type 2 diabetes and individuals without diabetes 65 years and older. Our variable of interest was the first reimbursement for a vaccine against influenza over the period from 2009 to 2019. We identified 2540 cohort members with type 2 diabetes (<65 years n = 1583; ≥65 years n = 957). The population without diabetes (≥65 years) comprised 18,364 individuals. The factors related to the first influenza vaccination differed significantly between the persons with diabetes younger than 65 years and those aged at least 65 years: age (OR = 1.01/OR = 0.89—P-interaction<0.001), poor perceived health (OR = 1.24/OR = 0.79—P-interaction = 0.048), and indicators of diabetes treatment quality [at least 2 hbA1c assays/year (OR = 1.91/0 R = 0.90—P-interaction<0.001), and blood pressure < 140/90 (OR = 1.24/OR = 0.90—P-interaction = 0.059)]. The only factor related to first influenza vaccination significantly different between individuals aged at least 65 years with and without diabetes was age (OR = 0.83/OR = 1.05—P-interaction<0.001). This study shows that trials are now needed to test the effectiveness of age- and sex-specific messages to increase influenza vaccination coverage among people with diabetes. |
| format | Article |
| id | doaj-art-1f50c9846c384905a76360e01c22e863 |
| institution | Kabale University |
| issn | 2164-5515 2164-554X |
| language | English |
| publishDate | 2025-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj-art-1f50c9846c384905a76360e01c22e8632025-01-06T06:19:42ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2025-12-0121110.1080/21645515.2024.2437911Factors determining first influenza vaccination among individuals with type 2 diabetes in the CONSTANCES cohort by age group (younger than 65 years or 65 and older)Sylvain Paquet0Virginie Ringa1Henri Panjo2Jeanne Sassenou3Marie Zins4Laurent Rigal5Department of General Practice, University of Paris-Saclay, Paris, FranceCESP (Centre for Research in Epidemiology and Population Health), Inserm U1018, Université Paris-Saclay, équipe soins primaires et prévention institution, Villejuif, FranceCESP (Centre for Research in Epidemiology and Population Health), Inserm U1018, Université Paris-Saclay, équipe soins primaires et prévention institution, Villejuif, FranceDepartment of General Practice, University of Paris-Saclay, Paris, FranceINSERM, Population-based Epidemiologic Cohorts Units, Villejuif, FranceDepartment of General Practice, University of Paris-Saclay, Paris, FranceVaccine coverage against influenza is suboptimal among people with diabetes. Our principal objective was to study and compare the factors related to a first influenza vaccination in individuals with type 2 diabetes according to age group (<65 years and ≥ 65 years) and then to compare the older age group with diabetes to the general population of that age. This is a descriptive cross-sectional study within the French Constances cohort. The study populations were composed of people with type 2 diabetes and individuals without diabetes 65 years and older. Our variable of interest was the first reimbursement for a vaccine against influenza over the period from 2009 to 2019. We identified 2540 cohort members with type 2 diabetes (<65 years n = 1583; ≥65 years n = 957). The population without diabetes (≥65 years) comprised 18,364 individuals. The factors related to the first influenza vaccination differed significantly between the persons with diabetes younger than 65 years and those aged at least 65 years: age (OR = 1.01/OR = 0.89—P-interaction<0.001), poor perceived health (OR = 1.24/OR = 0.79—P-interaction = 0.048), and indicators of diabetes treatment quality [at least 2 hbA1c assays/year (OR = 1.91/0 R = 0.90—P-interaction<0.001), and blood pressure < 140/90 (OR = 1.24/OR = 0.90—P-interaction = 0.059)]. The only factor related to first influenza vaccination significantly different between individuals aged at least 65 years with and without diabetes was age (OR = 0.83/OR = 1.05—P-interaction<0.001). This study shows that trials are now needed to test the effectiveness of age- and sex-specific messages to increase influenza vaccination coverage among people with diabetes.https://www.tandfonline.com/doi/10.1080/21645515.2024.2437911Influenza vaccinetype 2 diabetesageepidemiologysexgender |
| spellingShingle | Sylvain Paquet Virginie Ringa Henri Panjo Jeanne Sassenou Marie Zins Laurent Rigal Factors determining first influenza vaccination among individuals with type 2 diabetes in the CONSTANCES cohort by age group (younger than 65 years or 65 and older) Human Vaccines & Immunotherapeutics Influenza vaccine type 2 diabetes age epidemiology sex gender |
| title | Factors determining first influenza vaccination among individuals with type 2 diabetes in the CONSTANCES cohort by age group (younger than 65 years or 65 and older) |
| title_full | Factors determining first influenza vaccination among individuals with type 2 diabetes in the CONSTANCES cohort by age group (younger than 65 years or 65 and older) |
| title_fullStr | Factors determining first influenza vaccination among individuals with type 2 diabetes in the CONSTANCES cohort by age group (younger than 65 years or 65 and older) |
| title_full_unstemmed | Factors determining first influenza vaccination among individuals with type 2 diabetes in the CONSTANCES cohort by age group (younger than 65 years or 65 and older) |
| title_short | Factors determining first influenza vaccination among individuals with type 2 diabetes in the CONSTANCES cohort by age group (younger than 65 years or 65 and older) |
| title_sort | factors determining first influenza vaccination among individuals with type 2 diabetes in the constances cohort by age group younger than 65 years or 65 and older |
| topic | Influenza vaccine type 2 diabetes age epidemiology sex gender |
| url | https://www.tandfonline.com/doi/10.1080/21645515.2024.2437911 |
| work_keys_str_mv | AT sylvainpaquet factorsdeterminingfirstinfluenzavaccinationamongindividualswithtype2diabetesintheconstancescohortbyagegroupyoungerthan65yearsor65andolder AT virginieringa factorsdeterminingfirstinfluenzavaccinationamongindividualswithtype2diabetesintheconstancescohortbyagegroupyoungerthan65yearsor65andolder AT henripanjo factorsdeterminingfirstinfluenzavaccinationamongindividualswithtype2diabetesintheconstancescohortbyagegroupyoungerthan65yearsor65andolder AT jeannesassenou factorsdeterminingfirstinfluenzavaccinationamongindividualswithtype2diabetesintheconstancescohortbyagegroupyoungerthan65yearsor65andolder AT mariezins factorsdeterminingfirstinfluenzavaccinationamongindividualswithtype2diabetesintheconstancescohortbyagegroupyoungerthan65yearsor65andolder AT laurentrigal factorsdeterminingfirstinfluenzavaccinationamongindividualswithtype2diabetesintheconstancescohortbyagegroupyoungerthan65yearsor65andolder |